Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03860103
Other study ID # RC19_0049
Secondary ID
Status Completed
Phase
First received
Last updated
Start date April 1, 2019
Est. completion date March 16, 2022

Study information

Verified date March 2022
Source Nantes University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

To identify fetuses small for their gestational-age who have reached their appropriate growth potential from growth-restricted fetuses due to placental insufficiency is uneasy. Intra Uterine Growth Restriction (IUGR) increases the risk for indicated preterm delivery, neonatal mortality and morbidity. Therefore, improving the knowledge of the placental perfusion is essential to better identify and manage fetal chronic oxygen deprivation associated with placental insufficiency. Thus, the investigators propose to study placental microcirculation with a more efficient Doppler than conventional Doppler use in clinical practice. The Ultrafast Doppler is being able to map placental blood flow and could have potential impact in placental insufficiency diagnosis and prevention. Moreover, this Doppler could discriminate maternal and fetal vascularization. The hypothesis is that Ultrafast Doppler could help clinician to diagnose and manage preeclampsia and IUGR during pregnancy.


Recruitment information / eligibility

Status Completed
Enrollment 165
Est. completion date March 16, 2022
Est. primary completion date March 16, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria: - Patient who accepted to participate in the study - Woman over 18 years old - Affiliated to a social security scheme - Mono-fetal pregnancy - Patients with normal pregnancy between 11 and 42 weeks of amenorrhea - Patients hospitalized for preeclampsia and / or intrauterine growth retardation, beyond 20 weeks of amenorrhea Exclusion Criteria: - Minors, adults under guardianship, protected persons - Not affiliated to a social security scheme - Multiple pregnancy

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
France Nantes University Hospital Nantes

Sponsors (1)

Lead Sponsor Collaborator
Nantes University Hospital

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Qualitative analysis (velocities) of intraplacental blood flow after acquisition of sequences in Ultrafast Doppler imaging from the 12 week of gestation
Primary Quantitative analysis (flow rates) of intraplacental blood flow after acquisition of sequences in Ultrafast Doppler from the 12 week of gestation